...
首页> 外文期刊>Journal of proteome research >Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple Myeloma
【24h】

Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple Myeloma

机译:骨髓成纤维样细胞的细胞外基质重塑与多发性骨髓瘤的疾病进展相关。

获取原文
获取原文并翻译 | 示例
           

摘要

The pathogenesis of multiple myeloma (MM) is regarded as a multistep process, in which an asymptomatic stage of monoclonal gammopathy of undetermined significance (MGUS) precedes virtually all cases of MM. Molecular events characteristic for the transition from MGUS to MM are still poorly defined. We hypothesized that fibroblast-like cells in the tumor microenvironment are critically involved in the pathogenesis of MM. Therefore, we performed a comparative proteome profiling study, analyzing primary human fibroblastlike cells isolated from the bone marrow of MM, of MGUS, as well as of non-neoplastic control patients. Thereby, a group of extracellular matrix (ECM) proteins, ECM receptors, and ECM-modulating enzymes turned out to be progressively upregulated in MGUS and MM. These proteins include laminin α_4, lysyl-hydroxylase 2, prolyl 4-hydroxylase 1, nidogen-2, integrin α_5β_5, c-type mannose receptor 2, PAI-1, basigin, and MMP-2, in addition to PDGF-receptor β and the growth factor periostin, which are likewise involved in ECM activities. Our results indicate that ECM remodeling by fibroblast-like cells may take place already at the level of MGUS and may become even more pronounced in MM. The identified proteins which indicate the stepwise progression from MGUS to MM may offer new tools for therapeutic strategies.
机译:多发性骨髓瘤(MM)的发病机理被认为是一个多步过程,在此过程中,几乎所有MM病例均先于无症状的意义不明的单克隆丙种球蛋白病(MGUS)出现。从MGUS过渡到MM的特征性分子事件仍知之甚少。我们假设肿瘤微环境中的成纤维细胞样细胞与MM的发病机制密切相关。因此,我们进行了比较蛋白质组分析研究,分析了从MM,MGUS以及非肿瘤性对照患者的骨髓中分离的原代人成纤维细胞样细胞。因此,一组细胞外基质(ECM)蛋白,ECM受体和ECM调节酶被证明在MGUS和MM中逐渐上调。这些蛋白质包括PDGF受体β和生长因子骨膜素,同样参与ECM活动。我们的结果表明,成纤维细胞样细胞的ECM重塑可能已经在MGUS水平发生,并且在MM中可能更加明显。鉴定出的指示MGUS向MM逐步发展的蛋白质可能为治疗策略提供新的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号